2024-04-30 13:19:08 ET
Nautilus Biotechnology, Inc. (NAUT)
Q1 2024 Earnings Conference Call
April 30, 2024 08:30 AM ET
Company Participants
Sujal Patel - Co-Founder & Chief Executive Officer
Parag Mallick - Co-Founder & Chief Scientist
Anna Mowry - Chief Financial Officer
Conference Call Participants
Presentation
Operator
Good day and thank you for standing by. Welcome to the Nautilus Biotechnology Q1 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Jeon E [ph]. Investor Relations. Please go ahead.
Unidentified Company Representative
Thank you. Earlier today, Nautilus released financial results for the quarter ended March 31, 2024. If you haven't received this news release or if you'd like to be added to the Company's distribution list, please send an e-mail to investorrelations@nautilus.bio. Joining me today from Nautilus are Sujal Patel, Co-Founder and CEO; Parag Mallick, Co-Founder and Chief Scientist; and Anna Mowry, Chief Financial Officer.
Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated....
Read the full article on Seeking Alpha
For further details see:
Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript